Ipamorelin / CJC-1295 NO DAC
GHRH / GHRP Blend
This research blend combines Ipamorelin (a selective GHRP) and CJC-1295 (a GHRH analogue) to study synergistic effects on growth hormone secretion. The combination targets both GHRH receptors and ghrelin receptors to maximize pulsatile GH release.
Available Sizes
Mechanism of Action
CJC-1295 binds GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and release. Ipamorelin selectively activates ghrelin receptors (GHS-R1a) to amplify GH pulses without significantly affecting cortisol or prolactin. Together they produce synergistic GH secretion.
Research Highlights
- Dual-mechanism GH secretagogue blend
- CJC-1295: GHRH receptor agonism with extended half-life
- Ipamorelin: selective ghrelin receptor activation
- Studied for body composition, recovery, and GH axis research
Product Specifications
Research Use Only. Ipamorelin / CJC-1295 NO DAC is sold exclusively for in vitro research and laboratory use. It is not intended for human or veterinary consumption, therapeutic use, or any other purpose. By purchasing, you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws.
